Accessibility Menu
 
Sharps Technology logo

Sharps Technology

(NASDAQ) STSS

Current Price$1.52
Market Cap$47.26M
Since IPO (2022)-100%
5 YearN/A
1 Year-80%
1 Month-8%

Sharps Technology Financials at a Glance

Market Cap

$47.26M

Revenue (TTM)

$204.12K

Net Income (TTM)

$282.50M

EPS (TTM)

$31.61

P/E Ratio

0.05

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.52

Volume

10,589

Open

$1.53

Previous Close

$1.52

Daily Range

$1.50 - $1.58

52-Week Range

$1.42 - $18.23

STSS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sharps Technology

Industry

Healthcare Equipment and Supplies

Employees

55

CEO

Paul K. Danner, III, MBA

Headquarters

Melville, NY 11747, US

STSS Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-1321%

Net Income Margin

-1384%

Return on Equity

-203%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$47.26M

Shares Outstanding

29.00M

Volume

10.59K

Short Interest

0.00%

Avg. Volume

592.78K

Financials (TTM)

Gross Profit

$413.32K

Operating Income

$269.74M

EBITDA

$269.74M

Operating Cash Flow

$10.99M

Capital Expenditure

$0.00

Free Cash Flow

$10.99M

Cash & ST Invst.

$10.38M

Total Debt

$0.00

Sharps Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.31M

N/A

Gross Profit

$594.00

+99.7%

Gross Margin

0.03%

N/A

Market Cap

$47.26M

N/A

Market Cap/Employee

$859.32K

N/A

Employees

55

N/A

Net Income

$182.66M

-3935.3%

EBITDA

$170.93M

-3815.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.38M

+458.1%

Accounts Receivable

$204.12K

+99.2%

Inventory

$645.27K

-65.5%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.05%

N/A

Return on Invested Capital

-1.02%

N/A

Free Cash Flow

$190.26M

+10516.3%

Operating Cash Flow

$752.88K

+142.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IXHLIncannex Healthcare Limited
$2.90-2.03%
CGTXCognition Therapeutics, Inc.
$0.87-2.63%
SERASera Prognostics, Inc.
$2.01-2.90%
RPIDRapid Micro Biosystems, Inc.
$2.27+5.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About STSS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.